Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data uniQure N.V. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
25.1
13.1
11.3
7.28
37.5
524
106
15.8
27.1
16.1
Cost of revenue
1.35
0.82
1.2
1.65
2.9
25
1.25
0.07
1.27
1.69
Gross profit
23.8
12.3
10.1
5.63
34.6
499
105
15.8
25.9
14.4
Research and development
72.5
72.2
74.8
94.7
122
144
198
215
144
141
Selling, general and administrative
26
24.6
25.3
33.5
42.6
56.3
55.1
74.6
52.7
65.5
Operating expenses
98.5
96.8
100
Operating income
-71.9
-71.3
-88.2
-121
-125
311
-143
-283
-184
-185
Interest expense
2.17
2.23
2.16
3.81
3.83
7.47
11.7
41.6
63.7
62
Interest income
0.07
0.12
2.73
3.55
0.94
0.16
0.61
19.6
21.4
17
Other non-operating income
0.79
-2.44
0.21
-2.53
0.48
-0.16
2.76
10.9
Pre-tax income
-72.2
-79.5
-83.1
-124
-141
333
-128
-307
-237
-193
Income tax
1.15
-0.2
0.23
-16.4
3.22
-1.47
1.92
2.43
5.63
Net income
-73.4
-79.3
-83.3
-124
-125
330
-127
-308
-240
-199
EBITDA
-66.4
-63.8
-75.8
-114
-115
318
-135
-271
-172
-171
EPS, basic
-2.93
-2.94
-2.34
-3.11
-2.81
7.17
-2.71
-6.47
-4.92
-3.46
EPS, diluted
-2.93
-2.94
-2.34
-3.11
-2.81
7.04
-2.71
-6.47
-4.92
-3.46
Shares, basic (weighted)
25
26,984
35,640
40
44.5
46
46.7
47.7
48.6
57.5
Shares, diluted (weighted)
25
26,984
35,640
40
44.5
46.8
46.7
47.7
48.6
57.5
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
132
159
235
378
245
556
228
241
159
80.2
Receivables
3.68
6.62
5.86
Inventory
6.92
12
Other current assets
1.27
0.69
0.33
0.75
3.02
10.5
11.8
15.1
9.28
20.5
Total current assets
144
163
237
384
259
628
477
652
390
656
Property, plant and equipment
35.7
34.3
29.2
28.8
32.3
43.5
50.5
46.5
20.4
13.8
Lease right-of-use assets
26.8
26.1
25.6
32.7
28.8
13.6
12.5
Goodwill
0.47
0.53
0.51
0.5
0.54
27.6
25.6
26.4
22.4
25.4
Intangible assets
8.32
9.57
5.2
5.43
3.36
62.7
58.8
60.5
71
72.8
Other non-current assets
1.83
2.48
2.75
5.9
6.06
3.18
1.4
5.56
Total assets
190
210
274
449
340
809
705
832
557
825
Accounts payable
5.52
2.91
3.79
5.68
3.77
2.5
11
6.59
7.23
5.17
Accrued liabilities
5.56
5.65
8.23
12.5
18
28.5
30.6
30.5
29.2
41.3
Deferred revenue
6.14
4.61
7.63
7.63
2.08
Short-term debt
0.61
1.05
Total current liabilities
22.7
19.2
20
31.6
27.3
36.8
75.9
73.7
40.1
62.9
Long-term debt
19.6
19.7
35.5
36.1
35.6
101
103
102
51.3
49.7
Lease liabilities
31.1
30.4
29
31.7
28.3
11.1
9.83
Other non-current liabilities
0.05
0.61
0.44
0.53
3.14
4.24
0.94
3.7
7.94
3.66
Total liabilities
127
120
94.3
126
96.5
213
229
624
563
626
Total debt
20.2
24
48.2
46.5
42.4
136
144
148
66
71.9
Paid-in capital
465
567
720
987
1,016
1,077
1,113
1,149
1,173
1,582
Retained earnings
-396
-475
-536
-660
-785
-455
-582
-890
-1,130
-1,329
Other comprehensive income
-6.56
-3.8
-7.26
-6.7
-9.9
-28.9
-58.3
-53.6
-52.8
-58.2
Shareholders' equity
63.6
89.4
180
323
244
596
476
208
-6.75
199
Total equity
63.6
89.4
180
323
244
596
476
208
-6.75
199
Total liabilities and equity
190
210
274
449
340
809
705
832
557
825
Shares outstanding
25.3
31,339
37,352
43.7
44.8
46.3
47
47.8
49
62.3
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-73.4
-79.3
-83.3
-124
-125
330
-127
-308
-240
-199
Depreciation and amortization
5.5
7.54
12.4
6.67
10.6
7.3
8.54
11.9
12.6
14.8
Stock-based compensation
6.21
10.3
10.7
17.5
21.8
25.6
34.2
35.1
22.3
17.7
Deferred income tax
1.15
-0.21
0.21
-16.4
3.21
-1.49
1.81
2.28
1.59
Change in inventory
0.48
-6.92
-6.74
2.42
Change in payables
0.34
-1.67
1.07
1.65
-2.7
-0.73
9.24
-4.17
1.52
-2.67
Cash from operations
-72.2
-64.3
-76
-98.7
-135
288
-145
-146
-183
-178
Capital expenditures
-15.3
-4.46
-2.38
-5.65
-7.27
-17.4
-17.7
-7.15
-3.37
-0.44
Acquisitions
-49.9
-1.9
Cash from investing
-17.2
-5.58
-4.25
-6.65
-9.48
-67.4
-183
-206
163
-322
Debt issued
14.8
64.1
Debt repaid
-1.57
-53.1
Stock issued
2.59
4.04
4.83
5.6
7.44
30.9
Cash from financing
2.45
90.1
158
249
7.44
94.9
1.45
363
-59.5
415
Exchange rate effect
-1.63
7.31
-2.19
-0.11
3.82
-3.76
-1.83
2.27
-4.97
5.66
Net change in cash
-88.5
27.5
75.5
143
-133
312
-328
13.4
-84.2
-78.5
Free cash flow
-87.5
-68.7
-78.4
-104
-142
271
-163
-153
-186
-178
Interest paid
2.35
1.62
2.14
3.12
4.13
6.54
9.25
16.9
20.6
25.1
Income taxes paid
0.01
0.02
7.54
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to March 31, 2026; growth uses fiscal years. Valuation uses the share price of $38.23 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
90.6%
Gross profit / revenue.
Operating margin
-1,060.0%
Operating income / revenue.
EBITDA margin
-986.8%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-1,123.0%
Pre-tax income / revenue.
Net margin
-1,154.0%
Net income / revenue.
FCF margin
-953.7%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-951.2%
Cash from operations / revenue.
Return on equity (ROE)
-139.9%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-26.8%
Net income / average total assets.
Return on invested capital (ROIC)
-255.5%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
739.0%
Research and development expense / revenue.
SG&A / revenue
412.4%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
101.5%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
2.5%
Capital expenditures / revenue.
D&A / revenue
72.9%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-40.6%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-46.7%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
-15.6%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
-44.3%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
-48.5%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
-16.1%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value CAGR, 3y
-25.2%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
-4.0%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
48.2%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
5.4%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
19.4%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
18.2%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
7.2%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
5.3%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
10.4x
Current assets / current liabilities.
Quick ratio
2.43x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
2.36x
(Cash + short-term investments) / current liabilities.
Debt / equity
0.33x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
6.4%
Total debt / total assets.
Liabilities / assets
80.8%
Total liabilities / total assets.
Net debt
-$90.1M
Total debt - cash - short-term investments. Negative means more cash than debt.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$0.29
Revenue / diluted weighted shares.
FCF per share
-$2.75
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$2.74
Cash from operations / diluted weighted shares.
Book value per share
$2.37
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
147x
Market cap / revenue.
P/B
17.8x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
48.6x
Market cap / tangible book value, when positive.
EV/Sales
142x
Enterprise value / revenue.
FCF yield
-6.5%
Free cash flow / market cap.
Earnings yield
-7.9%
Net income / market cap (the inverse of P/E).
What was uniQure N.V.'s revenue in fiscal 2025?
uniQure N.V. reported revenue of $16.1M for fiscal 2025, 40.6% lower than the year before.
Was uniQure N.V. profitable in fiscal 2025?
No. It reported a net loss of $199.0M.
How much free cash flow did uniQure N.V. generate in fiscal 2025?
Cash from operations of $178.0M minus capital expenditures of $439.0K left free cash flow of -$178.4M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.